XML 12 R5.htm IDEA: XBRL DOCUMENT v3.26.3
STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2024 $ 243,122 $ 7 $ 805,510 $ (562,774) $ 379
Beginning Balance (in shares) at Dec. 31, 2024   71,021,855      
Exercise of common stock options (in shares)   53,009      
Exercise of common stock options 253   253    
Issuance of common stock upon vesting of RSUs (in shares)   3,647      
Stock-based compensation expense 6,554   6,554    
Unrealized loss on investments (170)       (170)
Net loss (30,021)     (30,021)  
Ending Balance at Mar. 31, 2025 219,738 $ 7 812,317 (592,795) 209
Ending Balance (in shares) at Mar. 31, 2025   71,078,511      
Beginning Balance at Dec. 31, 2024 243,122 $ 7 805,510 (562,774) 379
Beginning Balance (in shares) at Dec. 31, 2024   71,021,855      
Unrealized loss on investments 236        
Ending Balance at Sep. 30, 2025 406,919 $ 11 1,068,030 (661,737) 615
Ending Balance (in shares) at Sep. 30, 2025   97,278,032      
Beginning Balance at Mar. 31, 2025 219,738 $ 7 812,317 (592,795) 209
Beginning Balance (in shares) at Mar. 31, 2025   71,078,511      
Issuance of common stock, net 133,269 $ 2 133,267    
Shares of common stock issued   14,980,313      
Exercise of common stock options (in shares)   7,812      
Exercise of common stock options 34   34    
Issuance of common stock upon vesting of RSUs (in shares)   17,752      
Issuance of common stock from ESPP, shares   102,940      
Issuance of common stock from ESPP, value 757   757    
Stock-based compensation expense 6,574   6,574    
Unrealized loss on investments (22)       (22)
Net loss (36,355)     (36,355)  
Ending Balance at Jun. 30, 2025 323,995 $ 9 952,949 (629,150) 187
Ending Balance (in shares) at Jun. 30, 2025   86,187,328      
Issuance of common stock, net 108,703 $ 1 108,702    
Shares of common stock issued   10,930,032      
Exercise of common stock options (in shares)   144,301      
Exercise of common stock options 749 $ 1 748    
Issuance of common stock upon vesting of RSUs (in shares)   16,371      
Stock-based compensation expense 5,631   5,631    
Unrealized loss on investments 428       428
Net loss (32,587)     (32,587)  
Ending Balance at Sep. 30, 2025 406,919 $ 11 1,068,030 (661,737) 615
Ending Balance (in shares) at Sep. 30, 2025   97,278,032      
Beginning Balance at Dec. 31, 2025 $ 384,362 $ 11 1,075,807 (692,242) 786
Beginning Balance (in shares) at Dec. 31, 2025 98,528,949 98,528,949      
Issuance of common stock, net $ 59,888 $ 0 59,888    
Shares of common stock issued   4,698,400      
Exercise of common stock options (in shares)   253,847      
Exercise of common stock options 1,252   1,252    
Issuance of common stock upon vesting of RSUs (in shares)   5,216      
Stock-based compensation expense 6,898   6,898    
Unrealized loss on investments (1,076)       (1,076)
Net loss (35,767)     (35,767)  
Ending Balance at Mar. 31, 2026 415,557 $ 11 1,143,845 (728,009) (290)
Ending Balance (in shares) at Mar. 31, 2026   103,486,412      
Beginning Balance at Dec. 31, 2025 $ 384,362 $ 11 1,075,807 (692,242) 786
Beginning Balance (in shares) at Dec. 31, 2025 98,528,949 98,528,949      
Exercise of common stock options (in shares) 473,113        
Unrealized loss on investments $ (2,477)        
Ending Balance at Sep. 30, 2026 $ 339,503 $ 11 1,158,760 (817,577) (1,691)
Ending Balance (in shares) at Sep. 30, 2026 103,865,706 103,865,706      
Beginning Balance at Mar. 31, 2026 $ 415,557 $ 11 1,143,845 (728,009) (290)
Beginning Balance (in shares) at Mar. 31, 2026   103,486,412      
Exercise of common stock options (in shares)   30,976      
Exercise of common stock options 149   149    
Issuance of common stock upon vesting of RSUs (in shares)   13,093      
Issuance of common stock from ESPP, shares   105,943      
Issuance of common stock from ESPP, value 679   679    
Stock-based compensation expense 7,091   7,091    
Unrealized loss on investments (728)       (728)
Net loss (41,492)     (41,492)  
Ending Balance at Jun. 30, 2026 381,256 $ 11 1,151,764 (769,501) (1,018)
Ending Balance (in shares) at Jun. 30, 2026   103,636,424      
Exercise of common stock options (in shares)   188,290      
Exercise of common stock options 806   806    
Issuance of common stock upon vesting of RSUs (in shares)   40,992      
Stock-based compensation expense 6,190   6,190    
Unrealized loss on investments (673)       (673)
Net loss (48,076)     (48,076)  
Ending Balance at Sep. 30, 2026 $ 339,503 $ 11 $ 1,158,760 $ (817,577) $ (1,691)
Ending Balance (in shares) at Sep. 30, 2026 103,865,706 103,865,706